Rankings
▼
Calendar
PCRX FY 2025 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena
PCRX
Pacira BioSciences, Inc.
$971M
FY 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$726M
+3.6% YoY
Gross Profit
$519M
71.5% margin
Operating Income
$28M
3.9% margin
Net Income
$7M
1.0% margin
EPS (Diluted)
$0.16
Cash Flow
Operating Cash Flow
$152M
Free Cash Flow
$137M
Stock-Based Comp.
$58M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$572M
Stockholders' Equity
$693M
Cash & Equivalents
$159M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$726M
$701M
+3.6%
Gross Profit
$519M
$531M
-2.1%
Operating Income
$28M
-$73M
+138.3%
Net Income
$7M
-$100M
+107.1%
← Q4 2024
All Quarters
Q1 2025 →